Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

Autor: Ingrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, Fionnuala Ní Áinle, Bernard Tardy, Jennifer Donnelly, Peter Verhamme, Anne F Jacobsen, Anette T Hansen, Marc A Rodger, Maria T DeSancho, Roman G Shmakov, Nick van Es, Martin H Prins, Céline Chauleur, Saskia Middeldorp, Eline S van den Akker, Mireille N Bekker, Thomas van Bemmel, Laurent Bertoletti, Julie Blanc, Suzanne M Bleker, Aude Bourtembourg-Matras, Florence Bretelle, Bridgette Byrne, Francis Couturaud, Pierre Delorme, Elise S Eerenberg, Maureen TM Franssen, Jens Fuglsang, Wessel Ganzevoort, François Goffinet, Jiska M de Haan-Jebbink, Wieteke Heidema, Monique A Hertzberg, Marcel MC Hovens, Menno V Huisman, Leonie de Jong-Speksnijder, Pieter-Willem Kamphuisen, Denis J O'Keeffe, Karine Lacut, Josje Langenveld, M Simone Lunshof, Caroline P Martens, Adel Merah, Emmanuelle Le Moigne, Dimitri NM Papatsonis, Gilles Pernod, Franck Perrotin, Edith Peynaud-Debayle, Fabrice Pierre, Geneviève Plu Bureau, Tiphaine Raia-Barjat, Robbert JP Rijnders, Roger Rosario, Marc Ruivard, Jeannot Schmidt, Marieke Sueters, Thomas Vanassche, Marie-Noëlle Varlet, Alexandre J Vivanti, Matthieu Y van der Vlist, Lucet F van der Voet, Karlijn C Vollebregt, Johanna IP de Vries, Sabina de Weerd, Peter E Westerweel, Lia DE Wijnberger, Marije ten Wolde, Paula F Ypma, Catherine Zuily-Lamy, Joost J Zwart, Alexandra Benachi, Gaël Beucher, Holy Bezanahary, Karin de Boer, Marjon A. de Boer, Frantz Bousquet, Henk A. Bremer, Luc Bressollette, Aurélie Brossard, Cécile Chau, Brian Cleary, Fabienne Comte, Thomas Corsini, Anne Coustel, Barbara Debaveye, Raoul Desbrière, Cécile Duvillard, Astrid Eckman, Jeroen Eikenboom, Antoine Elias, Laura M. Faber, Emile Ferrari, Denis Gallot, Emilie Gauchotte, Ingrid Gaugler, Abby E. Geerlings, Audrey O'Gorman, Vincent Grobost, Pieter-Kees de Groot, David P. van der Ham, Brenda Hermsen, Kim Kamphorst, Alan Karovitch, Gunilla Kleiverda, Aiste Kloster, Annemarieke Koops, Inneke Krabbendam, Marieke J.H.A. Kruip, Saskia Kuipers, Judith van Laar, Damien Laneelle, Suzanne Lima, Peter MacMahon, Laurent Mandelbrot, Claudia A. van Meir, Caroline Menez, Leonard P. Morssink, Nathalie Moulin, Eve Mousty, Matthieu Muller, Lucy Murphy, Kathelijne Peerlinck, Alma O'Reilly, Maartje de Reus, Magali Hilmi Le Roux, Kevin Ryan, Bettina Samren, Daniela Schippers, Nico Schuitemaker, Chloé Schweizer, Hanneke van der Straaten, Cécile Tromeur, Kristine Vanheule, Tamara Verhagen, Jantien Visser, Michael Watts, Wim J. van Wijngaarden, Mallory Woiski, Maartje Zelis

Publikováno v: The Lancet, 400(10365), 1777-1787. Elsevier Limited
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787

Item does not contain fulltext BACKGROUND: Pregnancy-related venous thromboembolism is a leading cause of maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum women with a history of venous thromboembolism

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8643920b0d7863c0bf84cfcc765abbb7
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9

An ehealth application for the management of obstetric care

Autor: Karlijn van Stralen, Rebecca C Painter, Murielle Schagen, Martine De Bruine, Pieter-Kees De Groot

Publikováno v: International Journal of Integrated Care; Vol 18: Annual Conference Supplement 2018; 229

Introduction: Integral obstetric care is currently being implemented in the Netherlands in various models of care. In the Netherlands pregnant women are primarily cared for by midwifes and depending on the obstetrical healthcare plan of the women the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1abbfe89d843125d2d599a8c46b1373a
https://doi.org/10.5334/ijic.s2229